HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland:: An analysis of 622 nuclear families

被引:123
作者
Hermann, R
Turpeinen, H
Laine, AP
Veijola, R
Knip, M
Simell, O
Sipilä, I
Åkerblom, HK
Ilonen, J
机构
[1] Univ Turku, Dept Virol, FIN-20520 Turku, Finland
[2] Turku Univ, JDRF Ctr Prevent Type 1 Diabet Finland, Turku, Finland
[3] Turku Univ, Dept Paediat, Turku, Finland
[4] Oulu Univ, Dept Paediat, Oulu, Finland
[5] Univ Helsinki, Hosp Children Adolescents, Helsinki, Finland
来源
TISSUE ANTIGENS | 2003年 / 62卷 / 02期
关键词
genetic susceptibility; HLA DQ; population screening; type; 1; diabetes;
D O I
10.1034/j.1399-0039.2003.00071.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The diabetes predisposing effect of HLA genes is defined by a complex interaction of various haplotypes. We analyzed the disease association of HLA DRB1-DQA1-DQB1 genotypes in a large nuclear family cohort (n = 622) collected in Finland. Using the affected family based artificial control approach we aimed at characterizing all detectable disease-specific HLA haplotype and genotype effects. The DRB1*0401-DQB1*0302 haplotype was the most prevalent disease susceptibility haplotype in the Finnish population followed by (DR3)-DQA1*05-DQB1*02 and DRB1*0404-DQB1*0302. DRB1*0405-DQB1*0302 conferred the highest disease risk, although this haplotype was very rare. The DRB1*04-DQB1*0304 was also associated with increased disease risk, an effect detected for the first time in the Finnish population. The following haplotypes showed significant protection from the disease and are listed in decreasing order of the strength of their effect: (DR7)-DQA1*0201-DQB1*0303, (DR14)-DQB1*0503, (DR15)-DQB1*0602, DRB1*0403-DQB1*0302, (DR13)-DQB1*0603, (DR11/12/13)-DQA1*05-DQB1*0301, (DR1)-DQB1*0501. In addition to the DRB1*0401/0404-DQB1*0302/(DR3)-DQA1*05-DQB1*02 genotype and DRB1*04-DQB1*0302 homozygous genotypes, heterozygous combinations DRB1*0401-DQB1*0302/(DR13)-DQB1*0604, similar to/(DR8)-DQB1*04, similar to/(DR9)-DQA1*03-DQB1*0303, similar to/(DR1)-DQB1*0501 and similar to/(DR7)-DQA1*0201-DQB1*02 were also disease-associated. As a new finding in this population, the (DR3)-DQA1*05-DQB1*02 homozygous and (DR3)-DQA1*05-DQB1*02/(DR9)-DQA1*03-DQB1*0303 heterozygous genotypes conferred disease susceptibility. Similarly, the DRB1*0401-DQB1*0302/(DR13)-DQB1*0603 genotype was disease predisposing, implying that DQB*0603-mediated protection from diabetes is not always dominant. Comparison of our findings with published data from other populations indicates a significant disease-specific heterogeneity of the (DR8)-DQB1*04, (DR7)-DQA1*0201-DQB1*02 and (DR3)-DQA1*05-DQB1*02 haplotypes.
引用
收藏
页码:162 / 169
页数:8
相关论文
共 39 条
[11]   Estimation of genetic risk for type 1 diabetes [J].
Ilonen, J ;
Sjöroos, M ;
Knip, M ;
Veijola, R ;
Simell, O ;
Åkerblom, HK ;
Paschou, P ;
Bozas, E ;
Havarani, B ;
Malamitsi-Puchner, A ;
Thymelli, J ;
Vazeou, A ;
Bartsocas, CS .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 115 (01) :30-36
[12]   Incidence of childhood type 1 diabetes worldwide [J].
Karvonen, M ;
Viik-Kajander, M ;
Moltchanova, E ;
Libman, I ;
LaPorte, R ;
Tuomilehto, J .
DIABETES CARE, 2000, 23 (10) :1516-1526
[13]   Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes [J].
Kawabata, Y ;
Ikegami, H ;
Kawaguchi, Y ;
Fujisawa, T ;
Shintani, M ;
Ono, M ;
Nishino, M ;
Uchigata, Y ;
Lee, I ;
Ogihara, T .
DIABETES, 2002, 51 (02) :545-551
[14]   Prediction and prevention of type 1 diabetes [J].
Knip, M .
ACTA PAEDIATRICA, 1998, 87 :54-62
[15]   Feasibility of genetic and immunological prediction of Type I diabetes in a population-based birth cohort [J].
Kupila, A ;
Muona, P ;
Simell, T ;
Arvilommi, P ;
Savolainen, H ;
Hämäläinen, AM ;
Korhonen, S ;
Kimpimäki, T ;
Sjöroos, M ;
Ilonen, J ;
Knip, M ;
Simell, O .
DIABETOLOGIA, 2001, 44 (03) :290-297
[16]   Immunogenetics of HLA class II in Israeli Ashkenazi Jewish, Israeli non-Ashkenazi Jewish, and in Israeli Arab IDDM patients [J].
Kwon, OJ ;
Brautbar, C ;
Weintrob, N ;
Sprecher, E ;
Saphirman, C ;
Bloch, K ;
Pinhas-Hamiel, O ;
Assah, S ;
Vardi, P ;
Israel, S .
HUMAN IMMUNOLOGY, 2001, 62 (01) :85-91
[17]   HLA class II associated risk and protection against multiple sclerosis -: a Finnish family study [J].
Laaksonen, M ;
Pastinen, T ;
Sjöroos, M ;
Kuokkanen, S ;
Ruutiainen, J ;
Sumelahti, ML ;
Reijonen, H ;
Salonen, R ;
Wikström, J ;
Panelius, M ;
Partanen, J ;
Tienari, PJ ;
Ilonen, J .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 122 (1-2) :140-145
[18]   A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease [J].
Lie, BA ;
Sollid, LM ;
Ascher, H ;
Ek, J ;
Akselsen, HE ;
Ronningen, KS ;
Thorsby, E ;
Undlien, DE .
TISSUE ANTIGENS, 1999, 54 (02) :162-168
[19]   A SIMPLE SALTING OUT PROCEDURE FOR EXTRACTING DNA FROM HUMAN NUCLEATED CELLS [J].
MILLER, SA ;
DYKES, DD ;
POLESKY, HF .
NUCLEIC ACIDS RESEARCH, 1988, 16 (03) :1215-1215
[20]   Distribution of insulin-dependent diabetes mellitus (IDDM)-related HLA alleles correlates with the difference in IDDM incidence in four populations of the Eastern Baltic region [J].
Nejentsev, S ;
Koskinen, S ;
Sjöroos, M ;
Reijonen, H ;
Schwartz, EI ;
Kovalchuk, L ;
Sochnev, A ;
Adojaan, B ;
Podar, T ;
Knip, M ;
Simell, O ;
Koskenvuo, M ;
Åkerblom, HK ;
Ilonen, J .
TISSUE ANTIGENS, 1998, 52 (05) :473-477